Toward the Discovery of a Novel Class of YAP-TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP-TEAD Protein-Protein Interface

被引:37
|
作者
Gibault, Floriane [1 ]
Coevoet, Mathilde [1 ]
Sturbaut, Manon [1 ]
Farce, Amaury [2 ]
Renault, Nicolas [2 ]
Allemand, Frederic [3 ]
Guichou, Jean-Francois [3 ]
Drucbert, Anne-Sophie [4 ]
Foulon, Catherine [4 ]
Magnez, Romain [1 ]
Thuru, Xavier [1 ]
Corvaisier, Matthieu [1 ]
Huet, Guillemette [1 ]
Chavatte, Philippe [2 ]
Melnyk, Patricia [1 ]
Bailly, Fabrice [1 ]
Cotelle, Philippe [1 ,5 ]
机构
[1] Univ Lille, CHU Lille, INSERM,UMR S 1172, JPArc,Ctr Rech Jean Pierre Aubert Neurosci & Canc, F-59000 Lille, France
[2] Univ Lille, CHU Lille, LIRIC Lille Inflammat Res Int Ctr, INSERM,U995, F-59000 Lille, France
[3] Univ Montpellier, Ctr Biochim Struct, CNRS, INSERM,U1054,UMR5048, 29 Rue Navacelles, F-34090 Montpellier, France
[4] Univ Lille, CHU Lille, Plate Forme Interact Mol, F-59000 Lille, France
[5] ENSCL, F-59000 Lille, France
关键词
protein-protein interaction; YAP-TEAD disruption; molecular docking; binding assays; anticancer; ORGAN SIZE CONTROL; HIPPO PATHWAY; DOWNSTREAM EFFECTORS; CELL-PROLIFERATION; EMERGING ROLES; CANCER; YAP/TAZ; TAZ; COACTIVATORS; COMPLEX;
D O I
10.3390/cancers10050140
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Intrinsically disordered protein YAP (yes-associated protein) interacts with TEADs transcriptional factors family (transcriptional enhancer associated domain) creating three interfaces. Interface 3, between the Omega-loop of YAP and a shallow pocket of TEAD was identified as the most important TEAD zone for YAP-TEAD interaction. Using the first X-ray structure of the hYAP(50-71)-hTEAD1(209-426) complex (PDB 3KYS) published in 2010, a protein-protein interaction inhibitors-enriched library (175,000 chemical compounds) was screened against this hydrophobic pocket of TEAD. Four different chemical families have been identified and evaluated using biophysical techniques (thermal shift assay, microscale thermophoresis) and in cellulo assays (luciferase activity in transfected HEK293 cells, RTqPCR in MDA-MB231 cells). A first promising hit with micromolar inhibition in the luciferase gene reporter assay was discovered. This hit also decreased mRNA levels of TEAD target genes.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] A rational approach for discovery of inhibitors of YAP-TEAD interaction
    Chene, L.
    Soude, A.
    Valaire, C.
    Delaporte, S.
    Jacquet, S.
    Cambet, Y.
    Braccini, I.
    Barth, M.
    Montalbetti, C.
    Broqua, P.
    Fromond, C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 180 - 180
  • [2] Discovery of YAP-TEAD protein-protein interaction (PPI) inhibitors for cancer therapy
    Soude, Anne
    Barth, Martine
    Bocart, Stephanie
    Thoreau, Frederic
    Masson, Philippe
    Braccini, Isabelle
    Montalbetti, Christian
    Brogue, Pierre
    Fromond, Claudia
    CANCER RESEARCH, 2016, 76
  • [3] A rational approach for discovery of inhibitors of YAP-TEAD interaction
    Fromond, Claudia
    Chene, Laurent
    Soude, Anne
    Barth, Martine
    Montalbetti, Christian
    Broqua, Pierre
    CANCER RESEARCH, 2015, 75
  • [4] Optimization of a Class of Dihydrobenzofurane Analogs toward Orally Efficacious YAP-TEAD Protein-Protein Interaction Inhibitors
    Sellner, Holger
    Chapeau, Emilie
    Furet, Pascal
    Voegtle, Markus
    Salem, Bahaa
    Le Douget, Mickael
    Bordas, Vincent
    Groell, Jean-Marc
    Le Goff, Anne-Laure
    Rouzet, Christine
    Wietlisbach, Thomas
    Zimmermann, Thomas
    McKenna, Joseph
    Brocklehurst, Cara E. E.
    Chene, Patrick
    Wartmann, Markus
    Scheufler, Clemens
    Kallen, Joerg
    Williams, Gareth
    Harlfinger, Stephanie
    Traebert, Martin
    Dumotier, Berengere M.
    Schmelzle, Tobias
    Soldermann, Nicolas
    CHEMMEDCHEM, 2023, 18 (11)
  • [5] A novel anti-cancer compound development targeting YAP-TEAD protein-protein interaction
    Park, J. S.
    Shin, Y. K.
    Hong, E.
    Park, Y. H.
    Um, J.
    Lee, D.
    Kwon, H. S.
    Issabayeva, G.
    Kang, O. Y.
    Lim, B. H.
    Park, S. J.
    Lim, H. J.
    Jeung, H. C.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S37 - S37
  • [6] Discovery of YAP-TEAD protein-protein interaction inhibitors (PPI) for treating malignant pleural mesothelioma (MPM).
    Soude, Anne
    Barth, Martine
    Luccarini, Jean-Michel
    Delaporte, Severine
    Chirade, Florence
    Valaire, Christelle
    Boulay, Aude
    Cheret, Genevieve
    Dorchie, Marie
    Estivalet, Celine
    Tuya-Boustugue, Pascale
    Tranchand, Robin
    Jean, Didier
    Quetel, Lisa
    Assie, Jean-Baptiste
    Konstantinova, Irena
    Junien, Jean-Louis
    Broqua, Pierre
    MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 49 - 49
  • [7] Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma
    Jacquelyn T. Saunders
    Brent Holmes
    Angelica Benavides-Serrato
    Sunil Kumar
    Robert N. Nishimura
    Joseph Gera
    Journal of Neuro-Oncology, 2021, 152 : 217 - 231
  • [8] Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma
    Saunders, Jacquelyn T.
    Holmes, Brent
    Benavides-Serrato, Angelica
    Kumar, Sunil
    Nishimura, Robert N.
    Gera, Joseph
    JOURNAL OF NEURO-ONCOLOGY, 2021, 152 (02) : 217 - 231
  • [9] Identification of small molecule Pan-TEAD inhibitors disrupting YAP-TEAD protein-protein interaction and targeting gastric cancer cells
    Kumar, Ramesh
    Toh, Joel
    Thian, Joanne
    Mohideen, Noorul Farzana
    Sun, Jialin
    Chakraborty, Sayan
    Gunaratne, Jayantha
    Hong, Wanjin
    CANCER RESEARCH, 2024, 84 (07)
  • [10] Fluorescence polarization assay for the identification and evaluation of inhibitors at YAP-TEAD protein-protein interface 3
    Zhou, Wei
    Li, Yiping
    Song, Jinhua
    Li, Chenglong
    ANALYTICAL BIOCHEMISTRY, 2019, 586